press release
Published: 12 October 2026

AI system could transform rabies testing around the world

Rabies virus detection in cell cultures could soon become faster and more accessible, thanks to a world-first AI system developed by researchers at the University of Surrey’s Institute for People-Centred AI (PAI) in collaboration with the Rabies and Viral Zoonoses team at the Animal and Plant Health Agency (APHA). 

The breakthrough is designed to help improve surveillance of one of the world’s deadliest infectious diseases and deliver practical, laboratory-ready tools that can be adopted in endemic countries.

Despite being almost entirely preventable through vaccination, rabies causes around 59,000 human deaths every year. Current practices for diagnosis and measuring protective antibodies through vaccination still rely on specialists manually examining thousands of microscope images – which can be slow, labour-intensive and open to differences in interpretation. 

In a DEFRA-funded study published in Nature Scientific Reports, the research team created the first AI-based workflow capable of identifying rabies virus infection in cell cultures and accurately measuring antibody concentration levels.  

Using more than 2,300 fluorescence images containing over 36,000 annotated image sections, the team trained several deep learning models to recognise rabies virus infection within cells. The best-performing model correctly classified 99.6 per cent of samples and almost perfectly distinguished infected from uninfected cells, avoiding false alarms. 

The technology could help laboratories analyse samples more quickly and consistently, particularly in countries where rabies remains endemic and specialist expertise is limited. It could also reliably measure antibody levels used to assess vaccine protection and support international pet travel requirements.

The results establish a framework that can be adapted for the detection, analysis, and surveillance of other pathogens, supporting broader applications of AI across infectious disease research and diagnostics. 

We hope this innovation will help strengthen rabies surveillance and, ultimately, support global efforts to eliminate human deaths from this disease. This technology is now being further developed for use to detect the virus in infected brain tissue which we hope will transform international rabies diagnostic laboratories. Dr Lorraine M. McElhinney, Head of the National Reference Laboratory for Human and Animal Rabies at the APHA

###

Notes to editors 

Related sustainable development goals

Media Contacts


External Communications and PR team
Phone: +44 (0)1483 684380 / 688914 / 684378
Email: mediarelations@surrey.ac.uk
Out of hours: +44 (0)7773 479911